100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - Leases - Summary of Future Minimum Lease Payments for Operating Leases (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Condensed Statements of Operations link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Condensed Statements of Stockholders' (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Condensed Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Recent Issued Accounting Standards link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Fair Value link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Supplementary Balance Sheet Information link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Convertible Preferred Stock link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Warrants to Purchase Convertible Preferred Stock link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Revenue and Accounts Receivable Credit Concentration link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Net Loss per Common Share link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Fair Value (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Supplementary Balance Sheet Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Warrants to Purchase Convertible Preferred Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Revenue and Accounts Receivable Credit Concentration (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Net Loss per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Organization and Description of Business - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Fair Value - Summary of Fair Value of Outstanding Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Fair Value - Schedule of Reported Fair values of Contingent Consideration and Warrant Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Fair Value - Schedule of Changes in Contingent Consideration and Warrant Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Fair Value - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Supplementary Balance Sheet Information - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Supplementary Balance Sheet Information - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Supplementary Balance Sheet Information - Intangible Assets, Excluding Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Supplementary Balance Sheet Information - Schedule of Amortization Related to Remaining Net Intangible Assets Schedule to Amortize (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Supplementary Balance Sheet Information - Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Debt - Summary of Long-term Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Debt - Scheduled Principal Repayments (Maturities) of Long-term Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Leases - Summary of Future Minimum Lease Payments for Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Leases - Summary of Future Minimum Lease Payments for Operating Leases (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Convertible Preferred Stock - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Warrants to Purchase Convertible Preferred Stock - Summary of Activity for Convertible Preferred Stock Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Warrants to Purchase Convertible Preferred Stock - Summary of Activity for Convertible Preferred Stock Warrants Outstanding (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Revenue and Accounts Receivable Credit Concentration - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Revenue and Accounts Receivable Credit Concentration - Summary of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Revenue and Accounts Receivable Credit Concentration - Summary of Revenue and Accounts Receivable by Third-party Payors and Other Customers (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Share-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Share-Based Compensation - Summary of Share-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Share-Based Compensation - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Share-Based Compensation - Summary of Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Net Loss per Common Share - Schedule of Computation of Basic and Diluted Loss per Share Attributable to Stockholders (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Net Loss per Common Share - Schedule of Common Stock Equivalents Excluded from Diluted Net Loss Attributable to Common Stockholders (Details) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Subsequent Events (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink Business acquisition description Business Acquisition, Description of Acquired Entity Operating leases, 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Operating leases, 2023 Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Document Transition Report Document Transition Report Weighted Average Contractual Life (Years), Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Astrazeneca UK. Astrazeneca UK [Member] AstraZeneca UK Equity financing costs Payment of Equity Financing Costs Payment of equity financing costs. Rule 10b51 Arr Modified Flag Rule 10b51 Arr Modified Flag. Two Thousand Twenty One Term Loan and Promissory Note One [Member] Two Thousand Twenty One Term Loan and Promissory Note One [Member] 2021 Term Loan and Promissory Note One Direct Costs and Expenses Direct Costs And Expenses [Member] Direct costs and expenses. Geographical [Axis] Other Assets Other Assets Policy Text Block Other Assets Policy Text Block Release of restricted stock units Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than OptionsVested In Period Amount Share based compensation arrangement by share based payment award equity instruments other than optionsvested in period amount. Purchase agreement term Purchase Agreement Term Purchase agreement term. Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Changes in Contingent Consideration and Warrant Liabilities Debt Instruments [Abstract] Other Current Assets Other Current Assets [Member] Other Liabilities, Noncurrent, Total Other long-term liabilities Other Liabilities, Noncurrent Restricted Stock Units Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Share-Based Compensation Arrangements by Share-Based Payment Award, Option, Cancelled under the Option Exchange, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Option, Cancelled under the Option Exchange, Weighted Average Exercise Price Weighted Average Exercise Price, Cancelled under the Option Exchange Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date Expiration date Operating leases, 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Fair Value Fair Value Disclosures [Text Block] COLORADO Diagnostic Tests Diagnostic Tests [Member] Diagnostic tests. Percentage of license agreement and royalty payment related to Nodify CDT test recognized revenue for non-screening tests Percentage of revenue share payment related to nodify cdt test recognized revenue for non-screening tests. Percentage of revenue share payment related to nodify cdt test recognized revenue for non-screening tests. Summary of Revenue Disaggregation of Revenue [Table Text Block] Payments to Acquire Businesses, Net of Cash Acquired, Total Contingent consideration cash payment Payments to Acquire Businesses, Net of Cash Acquired Concentration Risk Type Concentration Risk Type [Axis] Deferred revenue Contract with Customer, Liability, Current Aggregate Intrinsic Value, Granted Share Based Compensation Arrangement By Share Based Payment Award Options Granted Aggregate Intrinsic Value Share based compensation arrangement by share based payment award options granted aggregate intrinsic value. Title of Individual [Domain] To be paid on September 30 2022. To Be Paid On September 30 2022 [Member] To be paid on September 30, 2022 Series E Preferred Stock Series E Preferred Stock [Member] Subsequent Events Subsequent Events [Text Block] Lessor reimbursements received. Lessor Reimbursements Received Lessor reimbursements received Contingent consideration Increase decrease in contingent consideration Increase decrease in contingent consideration. Principal balance outstanding Debt Instrument, Annual Principal Payment Aggregate principal amount outstanding Convertible preferred stock, issued Temporary Equity, Shares Issued Long-term operating lease liabilities Operating Lease, Liability, Noncurrent Schedule Of Stock By Class [Table] Schedule of Stock by Class [Table] Deferred Revenue Arrangement Type Deferred Revenue Arrangement Type [Axis] Fair Value Measurement Fair Value Measurement [Domain] Maximum percentage of common stock allowed to purchase by counterparty Maximum Percentage of Common Stock Allowed to Purchase by Counterparty Maximum percentage of common stock allowed to purchase by counterparty. Maturities of Long-Term Debt [Abstract] Current portion of contingent consideration Liabilities, Fair Value Disclosure, Total Liabilities, Fair Value Disclosure Debt Instrument, Unamortized Discount, Total Debt Instrument, Unamortized Discount Debt instrument, discount Class Of Stock [Line Items] Class of Stock [Line Items] First Amendment First Amendment. First Amendment [Member] Balance Sheet Location Balance Sheet Location [Axis] Total current assets Assets, Current Vesting [Domain] Extinguishment of Debt, Type [Domain] Fourth milestone payment and interest paid Fourth milestone and interest payment made Fourth milestone and interest payment made. Total liabilities and stockholders' equity Liabilities and Equity Subscription Agreements Subscription Agreements Member Subscription agreements. Entity Address, State or Province Entity Address, State or Province Second Amendment Second Amendment [Member] Second amendment. Stock Issued During Period, Value, New Issues Issuance of common stock, net Aggregate offering price Stock issuable per day, number of shares Reverse stock split ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Share-Based Compensation Arrangements by Share-Based Payment Award, Option, Granted under the Option Exchange, Weighted Average Exercise Price. Share-Based Compensation Arrangements by Share-Based Payment Award, Option, Granted under the Option Exchange, Weighted Average Exercise Price Weighted Average Exercise Price, Granted under the Option Exchange Stock Options, Outstanding - March 31, 2024 Stock Options, Outstanding - January 1, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Refundable deposit Customer Funds Trading Symbol Trading Symbol Debt Instrument, Redemption, Period Debt Instrument, Redemption, Period [Axis] Common Stock, Shares, Issued, Total Common stock, issued Common Stock, Shares, Issued 2026 Long-Term Debt, Maturity, Year Two Description on preferred stock voting right Preferred Stock, Voting Rights Minimum annual volume percentage thereafter Minimum Annual Volume Percentage Thereafter Minimum annual volume percentage thereafter. Numerator Net Income (Loss) Attributable to Parent [Abstract] Series G Preferred Stock Series G Preferred Stock [Member] Operating leases, 2029 and thereafter Lessee Operating Lease Liability Payments Due After Year Four Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Debt Instrument [Table] Schedule of Long-Term Debt Instruments [Table] Common Stock Balance, Shares Common Stock Balance, Shares Shares, Outstanding Remaining available capacity for share issuance Line of Credit Facility, Remaining Borrowing Capacity Operating leases, 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three Remaining estimated obligation Remaining Estimated Obligation Remaining estimated obligation. Number of shares reserved for issuance Common Stock, Capital Shares Reserved for Future Issuance Third Amendment Third Amendment [Member] Third amendment. Lease agreement number of options to extend Lease Agreement Number Of Options To Extend Lease agreement number of options to extend Percentage of royalty payments on net revenue Percentage Of Royalty Payments On Net Revenue Percentage of royalty payments on net revenue. Restricted Cash, Current, Statement of Financial Position [Extensible Enumeration] Restricted Cash, Current, Statement of Financial Position [Extensible Enumeration] Entity Address, City or Town Entity Address, City or Town Series A2 Preferred Stock Series A2 Preferred Stock [Member] Series A-2 preferred stock. Remainder of 2024 Long-Term Debt, Maturity, Remainder of Fiscal Year Weighted-average remaining lease term and discount rate associated with operating leases Operating leases, Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Inventory Other Inventory, Supplies, Gross Debt Debt Disclosure [Text Block] United healthcare. United Healthcare [Member] United Healthcare Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary of significant accounting policies. Tenant improvement allowances received. Tenant Improvement Allowances Received Tenant improvement allowances received Subsequent Event Subsequent Event [Member] Subsequent Event Type [Axis] Warrant Liabilities Fair Value Disclosure Warrant Liabilities Fair Value Disclosure Warrant liabilities Two Tranche Share-Based Payment Arrangement, Tranche Two [Member] Tranche B Loan Common Stock Purchase Agreement Common Stock Purchase Agreement Member Common stock purchase agreement member. Measurement Input, Expected Dividend Rate [Member] Dividend Yield Weighted Average Exercise Price, Forfeited/canceled Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Additional Paid-In Capital Additional Paid-in Capital [Member] Series B Preferred Stock Series B Preferred Stock [Member] Biopharma Services and Other Biopharma services and other [Member] Biopharma services and other. Current liabilities Liabilities, Current [Abstract] Percentage of royalty payments on net sales Percentage Of Royalty Payments On Net Sales Percentage of royalty payments on net sales. Business acquisition contingent consideration gross margin target Cash Acquired from Acquisition Current assets Assets, Current [Abstract] Warratns exercisable Class of warrant or right, additional warrants or rights exercisable. Class of Warrant or Right, Additional Warrants or Rights Exercisable Additional warratns exercisable Counterparty Name Counterparty Name [Axis] Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Statement of Stockholders' Equity [Abstract] Current portion of operating lease liabilities Operating Lease, Liability, Current Proceeds from issuance of common stock under employee stock purchase plan Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan Proceeds from issuance of common stock under employee stock purchase plan. Debt instrument maturity date Debt Instrument, Maturity Date (Accretion) amortization of lease right-of-use assets Operating Lease Right Of Use Asset Accretion Amortization Expense Operating lease right of use asset accretion amortization expense. Additional tenant improvement allowance amount. Additional Tenant Improvement Allowance Amount Additional Tenant improvement allowance Up Front Cash Payments Up-front Payment Arrangement [Member] Amount withdrawn Long-Term Debt Total Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Total property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Series A Preferred Stock Series A Preferred Stock [Member] Class of Stock Class of Stock [Domain] Provision for doubtful accounts Accounts Receivable, Credit Loss Expense (Reversal) Stock option exchange program. Stock Option Exchange Program [Member] Stock Option Exchange Program Remaining milestone payment Milestone Payment Remaining Amount Milestone payment remaining amount. Scenario [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Entity Central Index Key Entity Central Index Key Warrant issued to purchase shares Warrants to purchase shares of common stock Class of Warrant or Right, Number of Securities Called by Warrants or Rights Plan Name Plan Name [Domain] Other current assets Increase (Decrease) in Other Current Assets Non‑current assets Assets, Noncurrent [Abstract] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items]. Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred stock, outstanding Preferred Stock, Shares Outstanding Forfeited/canceled, warrants Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures Series F Preferred Stock Series F Preferred Stock [Member] Total current liabilities Liabilities, Current Entity Tax Identification Number Entity Tax Identification Number Summary of Future Minimum Lease Payments for Operating Lease Obligations Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Percentage of development and regulatory costs exercised using opt-out right Percentage Of Development And Regulatory Costs Exercised Using Opt Out Right Percentage of development and regulatory costs exercised using opt-out right. Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Payment of debt issuance costs Payments of Debt Issuance Costs Financial Instruments [Domain] Year of ending royalty payments from first commercial sale Year Of Ending Royalty Payments From First Commercial Sale Year of ending royalty payments from first commercial sale. Patent costs and intangible asset acquisition, net Payments For Proceeds From Patent Costs And Intangible Asset Acquisition Net Payments for proceeds from patent costs and intangible asset acquisition, net. Construction in Process Construction in Progress [Member] Issuance of common stock under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Milestone payment due date Milestone Payment Expiration Date Milestone payment expiration date. Series E Convertible Preferred Stock Warrants Series E Convertible Preferred Stock Warrants [Member] Series E convertible preferred stock warrants. Common Shares In Public Offerings Shares Common Shares In Public Offerings Shares Common Shares In Public Offerings Shares Lease option to extend Lessee, Operating Lease, Lease Not yet Commenced, Existence of Option to Extend [true false] Weighted-average Lease Term and Discount Rates Weighted Average Lease Term Discount Rate Finance Operating [Table Text Block] Weighted average lease term discount rate finance operating. Class Of Warrant Or Right [Line Items] Class of Warrant or Right [Line Items] Equity financing costs included in Accounts payable and other accrued liabilities. Equity Financing Costs Included in Accounts Payable and Other Accrued Liabilities Equity financing costs included in accounts payable and other accrued liabilities Plan Name Plan Name [Axis] Geographical [Domain] Operating lease, expiration term Lessee, Operating Lease, Term of Contract Total assets Assets Lease commencement date Lease Commencement Date Lease commencement Date Operating lease right-of-use assets Right of use assets Operating Lease, Right-of-Use Asset At-the-money Facility At-the-money Facility [Member] At-the-money facility. Entity Registrant Name Entity Registrant Name Current portion of notes payable Notes Payable to Bank, Current Gross proceeds from sale of common shares Proceeds from Issuance or Sale of Equity Proceeds from Issuance or Sale of Equity, Total Funding amount Lessee, Lease, Description [Line Items] Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Accumulated deficit Retained Earnings (Accumulated Deficit) Shares issued or issuable, threshold limit description Shares Issued or Issuable, Threshold Limit Description Shares issued or issuable, threshold limit description. Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Accumulated Deficit Retained Earnings [Member] Convertible Preferred Stock Class of Stock [Axis] Securities Purchase Agreements Securities Purchase Agreements [Member] Securities purchase agreements. Impairment loss on intangible assets Impairment of Intangible Assets, Finite-Lived Issuance of common stock under employee stock purchase plan, Shares Stock Issued During Period, Shares, Employee Stock Purchase Plans Minimum Minimum [Member] Capital expenditure for leasehold improvements related to leases premises which are tenant improvements Tenant Improvements Revenues, Total Revenues Revenues Proceeds from exercise of stock options Proceeds from Stock Options Exercised Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Number of Shares, Outstanding - March 31, 2022 Number of Shares, Outstanding - January 1, 2022 Restricted stock units outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Operating lease liability Operating Lease, Liability Total lease liabilities Scenario Forecast Forecast [Member] First Tranche Share-Based Payment Arrangement, Tranche One [Member] Tranche A Loan Equity Component Equity Component [Domain] Long-term notes payable Notes Payable, Noncurrent, Total Long‑term notes payable, net of current portion Notes Payable, Noncurrent Exit fee payment Exit Fee Payment Exit fee payment. Revenue Share Agreement Revenue Share Agreement [Member] Revenue share agreement. Revenue share expenses Revenue Share Expenses Revenue share expenses. Bonus-To-Options Program Bonus To Options Program [Member] Bonus-to-options program. Bio-Rad License Bio Rad License [Member] Bio-rad license. Adjustments to reconcile net loss to net cash, cash equivalents, and restricted cash used in operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net OID and debt issuance costs Unamortized debt discount and debt issuance costs Measurement Frequency Measurement Frequency [Axis] Debt Disclosure [Abstract] Debt Instrument, Basis Spread on Variable Rate Applicable margin rate Entity Current Reporting Status Entity Current Reporting Status Other Proceeds from (Payments for) Other Financing Activities Common stock, authorized Common Stock, Shares Authorized Research and Development Expense, Total Research and development Research and Development Expense Borrowings Long-Term Debt, Fair Value Landlord contribution towards cost of construction and tenant improvements Landlord Contribution Towards Cost of Construction and Tenant Improvements Landlord contribution towards cost of construction and tenant improvements Assets Assets [Abstract] Proceeds from the issuance of common stock Net proceeds Proceeds from the sale of common shares Proceeds from Issuance of Common Stock Amortization of Intangible Assets, Total Amortization expense of definite-lived intangible assets Amortization of Intangible Assets Common stock remained available for future issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Measurement Input, Expected Term [Member] Expected Term Convertible Preferred Stock Convertible Preferred Stock [Member] Common stock, $0.001 par value, 200,000,000 authorized; 97,159,448 (2024) and 96,235,883 (2023) shares issued and outstanding Aggregate market value of common stock and other equity securities Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Repayments of Long-term Debt, Total Repayment of term loan and notes payable Repayments of Long-Term Debt Amount used to retire outstanding debt Weighted average exercise price, Granted Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price Share based compensation arrangements by share based payment award non options grants in period weighted average exercise price. Lease description Lessee, Operating Lease, Lease Not yet Commenced, Description Revenue recognized Contract with Customer, Liability, Revenue Recognized Furniture and Fixtures Furniture and Fixtures [Member] Total accrued liabilities Accrued liabilities Accrued Liabilities, Current Current Fiscal Year End Date Current Fiscal Year End Date Share-based Payment Arrangement, Noncash Expense, Total Share-Based Payment Arrangement, Noncash Expense Share-based compensation expense Loss from operations Operating Income (Loss) Repayments of debt Repayments of Debt Repayments of Debt Ficlatuzumab Ficlatuzumab [Member] Ficlatuzumab. Inventory Inventory Supplies, Policy [Policy Text Block] Entity Ex Transition Period Entity Ex Transition Period Stock issued during period shares stock options granted under the option exchange. Stock issued during period shares stock options Granted under the Option Exchange Stock Options, Granted under the Option Exchange Income Tax Expense (Benefit), Total Provision for income taxes Income Tax Expense (Benefit) Deferred offering costs Deferred Offering Costs Convertible Debt Convertible Debt Securities [Member] Research and Development Research and Development Expense [Member] Long-Term Debt, Maturity, Year Four 2027 Payment of contingent consideration Payment for Contingent Consideration Liability, Financing Activities Lessee, Leases [Policy Text Block] Leases Concentration risk, percentage Concentration Risk, Percentage Total share-based compensation expense Stock compensation expense Share-Based Payment Arrangement, Expense Operating Expense Operating Expense [Member] Number of blood based lung cancer test Number Of Cancer Test Number of cancer test. Indefinite-lived Intangible Assets Indefinite-Lived Intangible Assets [Axis] Disaggregation Of Revenue [Table] Disaggregation of Revenue [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Percentage of shares of common stock underlying eligible options Registration Rights Agreement Registration Rights Agreement [Member] Registration rights agreement. Measurement Input Type [Domain] Lab Equipment Equipment [Member] Current and long-term operating lease liabilities Increase (Decrease) in Operating Lease Liability Contingent consideration arrangements, common shares, redemption amount Business Combination Contingent Consideration Arrangements Common Shares Redemption Amount Business combination contingent consideration arrangements common shares redemption amount. Concentration Risk [Line Items] Concentration Risk [Line Items] Intangible assets subject to amortization, Net Carrying Value Intangible assets subject to amortization, Net Carrying Value Finite-Lived Intangible Assets, Net, Ending Balance Finite-Lived Intangible Assets, Net, Beginning Balance Finite-Lived Intangible Assets, Net Series G Convertible Preferred Stock Warrants Series G Convertible Preferred Stock Warrants [Member] Series G convertible preferred stock warrants. Cash paid for income taxes Income Taxes Paid Revenue and Accounts Receivable Credit Concentration Revenue from Contract with Customer [Text Block] Initial warrants amount. Initial warrants amount Initial warrants amount Reduction in contingent consideration Reduction in contingent consideration Aggregate Intrinsic Value, Outstanding - March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Outstanding - January 1, 2023 Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Debt instrument, aggregate principal amount Debt Instrument, Face Amount Measurement Basis Measurement Basis [Axis] Other (expense) income, net Other Nonoperating Income (Expense) Total other expense Contingent consideration Business Combination, Contingent Consideration, Liability, Noncurrent Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Changes in fair value, net Operating expenses: Operating Expenses [Abstract] Long-term Debt, Type Long-Term Debt, Type [Domain] Depreciation, Depletion and Amortization, Nonproduction, Total Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Subsequent Events [Abstract] Cash collateralized letter of credit member. Cash Collateralized Letter of Credit [Member] Cash Collateralized Letter of Credit Adjustments to additional paid-in capital deferred offering costs Adjustments to additional paid-in capital deferred offering costs. Number of Shares, Outstanding - March 31, 2024 Number of Shares, Outstanding - January 1, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Commitments and Contingencies Disclosure [Abstract] Other Assets, Noncurrent, Total Other long-term assets Other Assets, Noncurrent Stock Options, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Other expenses Other Accrued Liabilities, Current Equity Equity [Text Block] Depreciation, Total Depreciation expense Depreciation Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for interest 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Issuance of common stock for deferred offering costs, Shares Stock Issued During Period, Shares, For Deferred Offering Costs Stock issued during period, shares, for deferred offering costs. PPP Loan P P P Loan [Member] PPP loan. Additional Paid in Capital, Ending Balance Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Total Additional paid‑in capital Additional Paid in Capital Fourth Amendment to 2021 Term Loan Fourth amendment to 2021 term loan [Member] Fourth amendment to 2021 term loan. Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Initial fairvalue of additional warrants Extinguishment of Debt [Axis] Stockholders' equity Equity, Attributable to Parent [Abstract] Series D Preferred Stock Series D Preferred Stock [Member] Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Summary of Components of Lease Expense Lease, Cost [Table Text Block] Summary of Activity for Convertible Preferred Stock Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Denominator Earnings Per Share [Abstract] Summary of Future Minimum Lease Payments for Operating Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Indefinite-lived Intangible Assets, Major Class Name Indefinite-Lived Intangible Assets, Major Class Name [Domain] LPC Facility L P C Facility [Member] LPC facility. The State of Colorado The State of Colorado Member The State of Colorado. Loss Contingencies [Table] Loss Contingencies [Table] Accounting Policies [Abstract] Lessee, Lease, Description [Table] Percentage of interest on installment payments Percentage Of Interest On Contingent Consideration Percentage of interest on contingent consideration. Public offering price per share of common stock. Public offering price per share of common stock Public offering price per share of common stock Weighted average exercise price, Outstanding - September 30, 2020, warrants Weighted average exercise price, Outstanding - January 1, 2020, warrants Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price Share based compensation arrangement by share based payment award non options outstanding weighted average exercise price. Liability Class Liability Class [Axis] Scenario [Axis] Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentrations of Credit Risk and Other Uncertainties Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Tranche B Warrants Tranche B Warrants [Member] Tranche B warrants. Other Long-term Assets Other Noncurrent Assets [Member] Debt Instrument, Interest Rate, Effective Percentage Effective interest rate Lease term Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Number of quarterly installment Contingent consideration number of installments Business Acquisition Contingent Consideration Number Of Installments Business acquisition contingent consideration number of installments. Original issue discount associated with Promissory Note One Original issuance discount Original issuance discount. Fourth milestone payment and interest Fourth milestone payment and interest Fourth milestone payment and interest. Number of commercial blood-based test Number Of Commercial Blood Based Test Number of commercial blood based test. Number of Shares, Forfeited/canceled Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Number of Shares, Forfeited/canceled Net loss per share, basic Earnings Per Share, Basic Earnings Per Share, Basic, Total Customer Concentration Risk Customer Concentration Risk [Member] Inventory excess and obsolescence Inventory Write-down Excess and obsolete inventory Commitments and contingencies Commitments and Contingencies Leased property building capacity Leased Property Building Capacity Leased property building capacity. Income Statement [Abstract] At-The-Market Offering At The Market Offering [Member] At The Market Offering [Member] Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Accounts payable and other accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Indefinite-lived Intangible Assets (Excluding Goodwill), Ending Balance Indefinite-lived Intangible Assets (Excluding Goodwill), Beginning Balance Indefinite-lived Intangible Assets (Excluding Goodwill), Total Intangible assets not subject to amortization, Net Carrying Value Indefinite-Lived Intangible Assets (Excluding Goodwill) Issuance of warrants Adjustments to Additional Paid in Capital, Warrant Issued Underwritten Offering Underwritten Offering [Member] Underwritten offering. Measurement Input Type [Axis] Statistical Measurement Statistical Measurement [Domain] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Net Cash Provided by (Used in) Operating Activities Net cash and cash equivalents and restricted cash used in operating activities Business combination contingent consideration final payment Business Combination Contingent Consideration Final Payment Business combination contingent consideration final payment. Period End Date Document Period End Date Document Period End Date Statistical Measurement Statistical Measurement [Axis] Accounts Receivable, Allowance for Credit Loss, Ending Balance Accounts Receivable, Allowance for Credit Loss, Beginning Balance Allowance for doubtful accounts receivable Accounts Receivable, Allowance for Credit Loss 2021 Term Loan Two Thousand Twenty One Term Loan [Member] Two thousand twenty one term loan. Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Stockholders' Equity Note [Abstract] Prior to Second Anniversary Debt Instrument, Redemption, Period Two [Member] Net loss per share, diluted Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Product and Service Product and Service [Domain] Other Other [Member] Other member. Concentration Risk Benchmark Concentration Risk Benchmark [Domain] Promissory Note Two Promissory Note Two [Member] Promissory note two. ATM Facility At The Market Facility [Member] At the market facility. Revenue from Contract with Customer [Abstract] Common Shares In Public Offerings Price Per Share Common Shares In Public Offerings Price Per Share Common shares in public offerings price per share. Business acquisition contingent consideration gross margin target period Business Acquisition Contingent Consideration Gross Margin Target Period Business acquisition contingent consideration gross margin target period. Debt Instrument, Name Debt Instrument, Name [Domain] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Stock Options Exercisable - March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Issuance of common stock for deferred offering costs Stock Issued During Period, Values, For Deferred Offering Costs Stock issued during period, values, for deferred offering costs. Deposits [Member] Additional warrants amount. Additional warrants amount Additional warrants amount Thereafter Debt Instrument, Redemption, Period Four [Member] Interest expense Fair Value Measurement With Unobservable Inputs Interest Expense Fair value measurement with unobservable inputs interest expense. Fair Value, Recurring Fair Value, Recurring [Member] Accrued interest, amortization of debt issuance costs and other Accrued Interest Amortization Of Debt Issuance Costs And Other Accrued interest, amortization of debt issuance costs and other. Scheduled Principal Repayments (Maturities) of Long-term Obligations Schedule of Maturities of Long-Term Debt [Table Text Block] Current Portion of Contingent Consideration Current Portion Of Contingent Consideration [Member] Current portion of contingent consideration. Operating lease right-of-use assets obtained in exchange for lease liabilities at adoption of ASC 842. Operating Lease Right-of-Use Assets Obtained in Exchange for Lease Liabilities at Adoption of ASC 842 Operating lease right-of-use assets obtained in exchange for lease liabilities at adoption of ASC 842 Shares issued as commitment fee, value Shares Issued as Commitment Fee, Value Shares issued as commitment fee, value. Collateral Held [Domain] Finite-Lived Intangible Assets, Major Class Name Finite-Lived Intangible Assets, Major Class Name [Domain] Fair Value Liabilities Measured On Recurring Basis [Table] Fair Value Liabilities Measured On Recurring Basis [Table] Disclosure of information about liabilities measured at fair value on recurring basis. Investment, Type [Extensible Enumeration] Stock Options, Exercised Exercise of stock options, shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Liabilities and Stockholders' (Deficit) Equity Liabilities and Equity [Abstract] Purchase Commitment, Excluding Long-Term Commitment [Domain] Number of preferred stock converted into common stock Number Of Preferred Stock Converted Into Common Stock Number of preferred stock converted into common stock. Fair Value Liabilities Measured On Recurring Basis [Line Items] Fair Value Liabilities Measured On Recurring Basis [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Private Placement Private Placement [Member] Notes Payable2018 Notes Member 2018 Notes Notes Payable2018 Notes [Member] Tenant improvement allowances expected to be received. Tenant improvement allowances expected to be received Warrants and Rights Note Disclosure [Abstract] Promissory notes. Promissory Notes Member Promissory Notes Number of common shares issuable upon conversion of preferred stock Preferred Stock, Convertible, Shares Issuable Measurement Input, Discount Rate [Member] Discount Rate 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Credit Facility [Domain] Operating leases, Less amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less amount representing interest Direct costs and expenses Direct Costs And Expenses Direct costs and expenses. Weighted Average Exercise Price, Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Equity Components Equity Components [Axis] Percentage of fee payments on net sales Percentage Of Fee Payments On Net Sales Percentage of fee payments on net sales. Accounts receivable Increase (Decrease) in Accounts Receivable CARES Act C A R E S Act [Member] CARES act. Board of Directors Board of Directors Chairman [Member] 2021 Term Loan partial repayment in April 2022 member. 2021 Term Loan Partial Repayment in April 2022 Two Thousand and Twenty One Term Loan Partial Repayment in April 2022 [Member] Percentage of license income generated from licensing Percentage of license income generated from licensing Percentage Of License Income Generated From Licensing Percentage of license income generated from licensing. Recent Issued Accounting Standards Accounting Standards Update and Change in Accounting Principle [Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value Per Share, Released Local Phone Number Local Phone Number Property, Plant and Equipment [Line Items] Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Sale of Stock Sale of Stock [Axis] Weighted Average Exercise Price, Exercisable - March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Reserve for inventory Inventory Valuation Reserves 2027 and thereafter Long Term Debt Maturities Repayments Of Principal In Year Three And Thereafter Long term debt maturities repayments of principal in year three and thereafter. Number of milestone payments remaining Number of Milestone Payments Remaining Number of milestone payments remaining. Percentage of common stock issued and outstanding required for conversion of securities Percentage of common stock issued and Outstanding Required for Conversion of securities Percentage of common stock issued and outstanding required for conversion of securities. Goodwill, Ending Balance Goodwill, Beginning Balance Goodwill, Total Goodwill Goodwill Third amendment to 2021 term loan member. Third Amendment to 2021 Term Loan Third Amendment to 2021 Term Loan [Member] Restricted cash deposits Restricted Cash, Current Intangible assets not subject to amortization, Cost Indefinite Lived Intangible Assets Excluding Goodwill Gross Indefinite lived intangible assets excluding goodwill gross. Notes Payable, Current, Total Less: current maturities Notes Payable, Current Statement of Cash Flows [Abstract] Responsible percentage of development and regulatory costs Percentage Of Development And Regulatory Costs Percentage of development and regulatory costs. Concentration Risk Benchmark Concentration Risk Benchmark [Axis] Number of facility Number of Facility Number of facility. Common stock, par value Common Stock, Par or Stated Value Per Share Service [Member] Services and Other Description of offering period under plan Description Of Offering Period Under Plan Description of offering period under plan. Loss Loss [Member] Loss member. Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Debt Instrument, Interest Rate, Stated Percentage Interest rate Amortized to expense period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] April 2024 Offering April Two Thousand Twenty Four Offering [Member] April two thousand twenty four offering. Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Maximum Maximum Maximum [Member] Number of SARS-CoV-2 test Number Of S A R S Co V2 Test Number of SARS-CoV-2 test. Private placement in net equity proceeds Aggregate purchase price Proceeds from Issuance of Private Placement 2021 Term Loan Principal Repayment Two Thousand Twenty One Term Loan Principal Repayment [Member] Two thousand twenty one term loan principal repayment. Issuance of Perceptive Warrants Issuance of Perceptive Warrants Issuance of perceptive warrants. Convertible preferred stock, outstanding Temporary Equity Balance, Shares Temporary Equity Balance, Shares Temporary Equity, Shares Outstanding Base rent per month from commencement date Base Rent Per Month From Commencement Date Base rent per month from commencement date. Series H Convertible Preferred Stock Series H Preferred Stock [Member] Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Share-based compensation Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value Adjustment of Warrants Change in fair value of warrant liability Change in fair value of warrant liability, net Change in fair value of warrant liability, net Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net decrease in cash and cash equivalents and restricted cash Contingent Consideration Member Contingent Consideration Contingent Consideration [Member] Total non‑current assets Assets, Noncurrent Estimated payment to third parties Estimated Payment To Third Parties Estimated payment to third parties. Intangible Assets, Gross (Excluding Goodwill), Total Intangible assets, Cost Intangible Assets, Gross (Excluding Goodwill) Interest Expense Interest Expense [Member] Series A3 Preferred Stock Series A3 Preferred Stock [Member] Series A-3 preferred stock. Purchases of property & equipment included in Accrued liabilities Purchases Of Property And Equipment Included In Accrued Liabilities Purchases of property and equipment included in accrued liabilities. Warrant liability. Warrant Liability [Member] Warrant Liability Warrant Liabilities Schedule of Common Stock Equivalents Excluded from Diluted Net Loss Attributable to Common Stockholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] City Area Code City Area Code Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Letter of Credit Letter of Credit [Member] Customer Customer [Domain] Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Sales, Marketing, General and Administrative Selling, General and Administrative Expenses [Member] Weighted-average shares outstanding, basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total Deferred Revenue Deferred Revenue [Domain] Warrants to Purchase Convertible Preferred Stock Warrants For Convertible Preferred Stock [Text Block] Warrants for convertible preferred stock. Lease expiration date Lease Expiration Month Year Lease expiration month year Employee Stock Purchase Plan Employee Stock [Member] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Description of lease Lessee, Operating Lease, Description Loss on extinguishment of liabilities, net Loss on extinguishment of liabilities, net Loss on extinguishment of liabilities Gain (Loss) on Extinguishment of Debt, Total Gain (Loss) on Extinguishment of Debt Loss on debt extinguishment Summary of Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Purchases of property & equipment included in accounts payable and accrued liabilities Purchases of property & equipment included in accounts payable and accrued liabilities Purchases of property & equipment included in accounts payable and accrued liabilities. Percentage of royalty payments not required on net revenue Percentage Of Royalty Payments Not Required To Pay On Net Revenue Percentage of royalty payments not required to pay on net revenue. Statement [Table] Statement [Table] Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Accounts Receivable Accounts Receivable [Member] Contingent Consideration Type Contingent Consideration Type [Domain] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Document Fiscal Period Focus Document Fiscal Period Focus Operating leases, Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Total non‑current liabilities Liabilities, Noncurrent Stock issuable per day, number of shares Sale of Stock, Stock Issuable Per Day, Shares Sale of stock, stock issuable per day, shares. Collateral Held [Axis] Operating leases, 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two Statement [Line Items] Statement [Line Items] Summary of Fair Value of Outstanding Borrowings Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Summary of Long-term Notes Payable Schedule of Long-Term Debt Instruments [Table Text Block] Total Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Balance Balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Interest expense due to passage of time and fixed payment schedule. Interest expense due to passage of time and fixed payment schedule Software and Software Development Costs [Member] Software Subsequent Event [Line Items] Warrants Warrant [Member] Centennial Valley Properties I, LLC Lease Agreement Centennial Valley Properties I, LLC Centennial Valley Properties I, LLC Lease Agreement [Member] Centennial Valley Properties I, LLC Lease Agreement. Royalty expense Royalty Expense Accounts receivable, net of allowance for doubtful accounts of $161 and $65 Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts Receivable, after Allowance for Credit Loss, Current Tenant improvements incurred during the period. Tenant Improvements Incurred During The Period Tenant improvements incurred during the period Customer Customer [Axis] Number of subscription agreement for which final closing to be delayed. Number of subscription agreement for which final closing to be delayed Common Stock Common Stock [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Lease renewal term Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term Warrants, expires period Warrants and Rights Outstanding, Maturity Date Term of royalty payments from first commercial sale Term Of Royalty Payments From First Commercial Sale Term of royalty payments from first commercial sale. Subscription agreements description Subscription Agreements Description Subscription agreements description. Deferred offering costs included in Accrued liabilities Deferred Offering Costs Included In Accrued Liabilities Deferred offering costs included in accrued liabilities. Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value 2020 Equity Incentive Plan Two Thousand Twenty Equity Incentive Plan [Member] 2020 equity incentive plan. Summary of Share-based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Options and Restricted Stock Units (RSUs) Options And Restricted Stock Units R S Us [Member] Options and restricted stock units (RSUs). Other current assets Other Assets, Current Measurement Input, Risk Free Interest Rate [Member] Risk-Free Interest Rate Aggregate Intrinsic Value, Exercisable - March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Promissory Note One Promissory Note One [Member] Promissory note one. Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Accrued legal contingency Loss Contingency Accrual Loss Contingency Accrual, Ending Balance Loss Contingency Accrual, Beginning Balance Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Deferred offering costs Deferred Offering Costs Expensed Deferred offering costs expensed. Common stock issued for deferred offering costs Common Stock Issued For Deferred Offering Costs Common stock issued for deferred offering costs. Cover Cover [Abstract] Selling, General and Administrative Expense, Total Sales, marketing, general and administrative Selling, General and Administrative Expense Rent after fixed escalation provisions Rent After Fixed Escalation Provisions Rent after fixed escalation provisions. Vesting [Axis] Document Fiscal Year Focus Document Fiscal Year Focus Final settlement payment of legal contingency Loss Contingency Accrual, Payments Income Taxes Paid, Net, Total Cash paid for income taxes Income Taxes Paid, Net Sale of Stock Sale of Stock [Domain] Weighted Average Grant Date Fair Value Per Share, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Patents Patents [Member] Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range Percentage Of Probabilities Of Contingent Consideration Successful Achievement Milestone Discount Rates Range Percentage of probabilities of contingent consideration successful achievement milestone discount rates range. Segment Reporting [Abstract] Prepaid milestone payment Prepayment of Milestone Payment Prepayment of milestone payment. Security Exchange Name Security Exchange Name Operating Leases, Rent Expense, Net, Total Rent expense Operating Leases, Rent Expense, Net Recent Issued Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Preferred Stock, Shares Issued, Total Preferred stock, issued Preferred Stock, Shares Issued Preferred stock, authorized Preferred Stock, Shares Authorized Milestone payment Milestone payment. Schedule Of Finite Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property and equipment, gross Property, Plant and Equipment, Gross Options to Purchase Common Stock Options To Purchase Common Stock [Member] Options to purchase common stock. Organization And Description Of Business [Abstract] Organization and description of business. Remaining capacity under tenant improvement allowances prior to reimbursements expected to be received Remaining capacity under tenant improvement allowances prior to reimbursements expected to be received. Notes payable, total Notes Payable Payments Payments of contingent consideration Fair Value Measurement with Unobservable Inputs Payments of Contingent Consideration Fair value measurement with unobservable inputs payments of contingent consideration. Operating lease right-of-use asset obtained in exchange for lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Industry Sector Industry Sector [Axis] Cash Collateralized Cash Collateralized [Member] Cash collateralized. Business Acquisition, Acquiree Business Acquisition, Acquiree [Domain] Financial Instrument [Axis] Warrants and Rights Outstanding, Term Warrants expected term Class Of Warrant Or Right [Table] Class of Warrant or Right [Table] Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Entity Emerging Growth Company Entity Emerging Growth Company Amendment Amendment Flag Amendment Flag Lincoln Park Lincoln Park Member Lincoln Park. Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] CellCarta License Cell Carta License [Member] CellCarta License. Schedule of future minimum Rental payments for operating and finance leases. Summary of Future Minimum Lease Payments for Operating and Finance Leases Summary of Future Minimum Rental Payments for Operating and Financing Leases Schedule of Future Minimum Rental Payments for Operating and Finance Leases IPO Initial Public Offering IPO [Member] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Schedule of Future Estimated Amortization Expense of Intangible Assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Supplemental Cash Flow Information Associated with Leasing Activities Supplemental Cash Flow Information Leases Operating and Finance [Table Text Block] Supplemental cash flow information leases operating and finance. Third Amendment to APA Agreement Third Amendment to APA Agreement [Member] Third amendment to APA agreement member. Leases [Abstract] Warrant issued to purchase shares Warrant issued to purchase shares Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Entity File Number Securities Act File Number Accretion of lease liability. Accretion Of Lease Liability Accretion of lease liability Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Preferred Stock, Convertible, Terms Period of escalations of sales Period Of Escalations Of Sales Period of escalations of sales. Accounts Payable Accounts Payable [Member] Operating leases, Remainder of 2024 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Operating leases, Remainder of 2022 Leases Lessee Operating and Finance Leases [Text Block] Lessee operating and finance leases. Warrants expiration date Class of Warrant or Right, Date from which Warrants or Rights Exercisable Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Cash, cash equivalents, and restricted cash ‑ beginning of period Cash, cash equivalents, and restricted cash ‑ end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents and restricted cash Balance Sheet Related Disclosures [Abstract] Series B1 Convertible Preferred Stock Series B1 Convertible Preferred Stock [Member] Series B-1 Convertible Preferred Stock. Net proceeds Net proceeds from sale of common shares after deducting underwriting discounts and commissions and offering expenses Proceeds From Issuance Of Common Stock Net Proceeds from issuance of common stock net. License expiry date License Agreement Expiry Date License agreement expiry date. Share-Based Payment Arrangement [Abstract] Warrants and Rights Outstanding, Measurement Input Warrants and rights outstanding, measurement input Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Principal Repayment Principal Repayment [Member] Principal repayment member. Debt issuance costs included in accounts payable and other accrued liabilities Debt issuance costs included in Accounts payable and other accrued liabilities. Debt Issuance Costs Included in Accounts Payable and Other Accrued Liabilities Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Debt Instrument Debt Instrument [Axis] Fair Value Estimate of Fair Value Measurement [Member] Weighted Average Grant Date Fair Value Per Share, March 31, 2024 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Schedule of Intangible Assets, Excluding Goodwill Schedule of Intangible Assets and Goodwill [Table Text Block] Total operating expenses Operating Expenses Summary of Revenue and Accounts Receivable by Third-party Payors and Other Customers Schedules of Concentration of Risk, by Risk Factor [Table Text Block] 2025 Long-Term Debt, Maturity, Year One Area of office space leased Area of Office Space Leased Area of office space leased. Entity Address, Address Line Two Entity Address, Address Line Two Preferred stock, $0.001 par value, 5,000,000 authorized; 0 (2024 and 2023) issued and outstanding Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Title of Individual [Axis] Investment Type Investment Type [Axis] Proceeds from net of debt issuance costs and original issue discounts Proceeds from Debt, Net of Issuance Costs Net proceeds from debt, after deducting debt issuance costs and expenses Warrant, exercise price Warrant, exercise price Class of Warrant or Right, Exercise Price of Warrants or Rights Class of Warrant or Right Class of Warrant or Right [Domain] Remaining unrecognized share based compensation expense for options and restricted stock units Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Non‑current liabilities Liabilities, Noncurrent [Abstract] Computer Equipment Computer Equipment [Member] Net Loss per Common Share Earnings Per Share [Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total Stock Options, Forfeited/canceled Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Existing Shareholders Shareholders existing shareholders member existing shareholders. Prepayment premium percentage of aggregate outstanding principal amount. Prepayment premium percentage of aggregate outstanding principal amount Prepayment premium percentage of aggregate outstanding principal amount Entity Address, Address Line One Entity Address, Address Line One Revenue Revenue Benchmark [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Number of officers. Number of Officers Number of officers KANSAS Antidilutive Securities Antidilutive Securities [Axis] Other current liabilities Other Liabilities, Current Other Liabilities, Current, Total Measurement Input, Price Volatility [Member] Volatility Supplementary Balance Sheet Information Supplemental Balance Sheet Disclosures [Text Block] Finite-Lived Intangible Assets, Gross, Total Intangible assets subject to amortization, Cost Finite-Lived Intangible Assets, Gross Restricted Cash, Total Restricted cash Restricted Cash Repurchase Repurchase [Member] Repurchase. Weighted Average Grant Date Fair Value Per Share, January 1, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance Subsequent Event Type [Domain] Weighted average exercise price, Forfeited/canceled Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price Share based compensation arrangement by share based payment award non-options forfeitures and expirations in period weighted average exercise price. Income Statement Location Income Statement Location [Axis] 2026 and thereafter Long-Term Debt, Maturity, Year Three Long-term Debt, Type Long-Term Debt, Type [Axis] Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Intangible assets, Accumulated Amortization Intangible Assets Accumulated Amortization Excluding Goodwill Amount of accumulated amortization of intangible assets, excluding goodwill. Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Interest rate on extra allowance amount Interest Rate on Extra Allowance Amount Interest rate on extra allowance amount Series C Preferred Stock Series C Preferred Stock [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Interest-bearing Deposits Interest-Bearing Deposits [Member] Shares issued Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Price per share Share Price Current portion of contingent consideration Business Combination, Contingent Consideration, Liability, Current Notes/Loan payable Long-Term Debt, Gross Finance lease right-of-use assets obtained in exchange for lease liabilities Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Product and Service Product and Service [Axis] Non-current deferred revenue Contract with Customer, Liability, Noncurrent Title of 12(b) Security Title of 12(b) Security Intangible assets subject to amortization, Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Perceptive Term Loan Perceptive term loan member. Perceptive Term Loan [Member] Perceptive Term Loan Facility Shares Committed Under ESPP Shares Committed Under E S P P [Member] Shares committed under ESPP. Industry Sector Industry Sector [Domain] Investments Investments [Domain] Trademarks Trademarks [Member] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Carrying Value Reported Value Measurement [Member] Exercised, warrants Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Long-term Line of Credit Long-Term Line of Credit Long-term Line of Credit, Total Portion at Fair Value Measurement [Member] [Default] Fair Value Disclosure Item Amounts [Default] Portion at Fair Value Measurement [Member] Concentration Risk [Table] Concentration Risk [Table] Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Integrated Diagnostics Asset Purchase Agreement Integrated Diagnostics Asset Purchase Agreement [Member] Integrated diagnostics asset purchase agreement member. Subsequent Event [Table] Litigation Claims and Assessments Litigation Claims And Assessments [Member] Litigation claims and assessments. Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Share-Based Payment Arrangement, Tranche Three [Member] Tranche C Loan Contingent Consideration by Type Contingent Consideration by Type [Axis] Share-Based Payment Arrangement, Plan Modification, Number of Grantees Affected Number of eligible holders elected to exchange Vehicles Vehicles [Member] Remainder of 2024 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Weighted Average Contractual Life (Years), Exercisable - March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term AVEO Oncology A V E O Oncology [Member] Aveo oncology. Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, outstanding Common Stock, Shares, Outstanding Integrated Diagnostics, Inc Integrated Diagnostics Inc [Member] Integrated Diagnostics, Inc. Share-Based Compensation Share-Based Payment Arrangement [Text Block] Weighted Average Grant Date Fair Value Per Share, Forefeited/canceled Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Contingent consideration shares Business Combination Contingent Consideration Shares Business combination contingent consideration shares. Concentration Risk Type Concentration Risk Type [Domain] Income Statement Location Income Statement Location [Domain] Weighted Average Exercise Price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Exercise price of options granted Commitment shares issuable on conditional basis Commitment Shares Issuable on Conditional Basis Commitment shares issuable on conditional basis. Document Type Document Type Document Type Shares of common stock issued upon conversion of Series A preferred stock Stock Issued During Period, Shares, Conversion of Convertible Securities Area of leased premised obligated to pay base rent Area of Leased Premised Obligated to Pay Base Rent Area of leased premised obligated to pay base rent. Stock issuable per day, value Sale of Stock, Stock Issuable Per Day, Value Sale of Stock, stock issuable per day, value. Fair Value by Liability Class Fair Value by Liability Class [Domain] Net Cash Provided by (Used in) Investing Activities Net cash and cash equivalents and restricted cash used in investing activities Diligence expense and legal fees. Diligence Expense and Legal Fees Diligence expenses and legal fees Document Quarterly Report Document Quarterly Report Purchase Commitment, Excluding Long-Term Commitment [Axis] Stock issued during period shares stock options cancelled under the option exchange. Stock issued during period shares stock options cancelled under the option exchange Stock Options, Cancelled under the Option Exchange Counterparty Name Counterparty Name [Domain] Net cash and cash equivalents and restricted cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Accrued clinical trial expense Accrued Clinical Trial Expense Current Accrued clinical trial expense current. Debt Instrument, Redemption, Period Debt Instrument, Redemption, Period [Domain] Entity Filer Category Entity Filer Category Balance Sheet Location Balance Sheet Location [Domain] Other long-term assets Increase (Decrease) in Other Noncurrent Assets Shares issued as commitment fee Sale of Stock, Shares Issued as Commitment Fee Sale of stock, shares issued as commitment fee. Total other expense Nonoperating Income (Expense) After Second Anniversary, Prior to October 19, 2025 Debt Instrument, Redemption, Period Three [Member] Noncash purchases of property and equipment Capital Expenditures Incurred but Not yet Paid Total liabilities Liabilities Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Total stockholders' (deficit) equity Balances Balances Equity, Attributable to Parent Primary sources of revenue, description Primary Sources Of Revenue Description Primary sources of revenue description. Purchased Technology Purchased Technology [Member] Purchased technology. Intangible assets, Net Carrying Value Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Net loss attributable to common stockholders Net loss Interest Expense, Total Interest expense Interest Expense Interest expense Class of Stock Disclosures [Abstract] Fair Value of Financial Instruments Fair Value Measurement, Policy [Policy Text Block] Convertible Preferred Stock Preferred Stock [Text Block] Statement of Financial Position [Abstract] Weighted-average shares outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted, Total Weighted average price per share. Weighted Average Price Per Share Weighted average price per share Credit Facility [Axis] Amortization of lease right-of-use assets Amortization of operating lease right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Price per share Shares Issued, Price Per Share Other (expense) income: Other Income and Expenses [Abstract] Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Reported Fair values of Contingent Consideration and Warrant Liabilities NSCLC POC Trial N S C L C P O C Trial [Member] Nsclc poc trial. 2021 Term Loan Partial Repayment 2021 Term Loan Partial Repayment [Member] 2021 term loan partial repayment. 2029 and thereafter Finite Lived Intangible Assets Amortization Expense Year Five And Thereafter Finite lived intangible assets amortization expense year five and thereafter. Common stock issuable, committed to purchase Stock Issuable During Period, Value, Committed Shares Stock issuable during period, value, committed shares. Patent costs included in accrued liabilities. Patent Costs Included In Accrued liabilities Patent costs included in Accrued liabilities Operating leases, Weighted-average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term 2021 Term Loan Amendment Two Thousand Twenty One Term Loan Amendment [Member] Two Thousand Twenty One Term Loan Amendment. Use of Estimates Use of Estimates, Policy [Policy Text Block] Income Taxes Income Tax Disclosure [Text Block] Weighted average exercise price, Exercised Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price Share based compensation arrangements by share based payment award non options exercises in period weighted average exercise price. Weighted Average Exercise Price, Outstanding - March 31, 2024 Weighted Average Exercise Price, Outstanding - January 1, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Finite Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Perceptive term loan facility. Perceptive Term Loan Facility [Member] Perceptive Term Loan Facility Schedule of Computation of Basic and Diluted Loss per Share Attributable to Stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Disaggregation Of Revenue [Line Items] Disaggregation of Revenue [Line Items] Leasehold Improvements Leasehold Improvements [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Fair Value Disclosures [Abstract] Prior to First Anniversary Debt Instrument, Redemption, Period One [Member] Equity Financing Programs Equity Financing Programs [Member] Equity Financing Programs. Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Measurement Frequency Measurement Frequency [Domain] Other Long-term Liabilities Other Noncurrent Liabilities [Member] Purchases of property & equipment included in Accrued liabilities Payments to Acquire Property, Plant, and Equipment, Total Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Number of Shares, Released Number of Shares, Released Release of restricted stock units, shares Number of Shares, Granted Granted, warrants Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Number of shares issued and sold Stock Issued During Period, Shares, New Issues Issuance of common stock, net, Shares Employee-related Liabilities, Current, Total Compensation related accruals Employee-related Liabilities, Current Deferred offering costs amortized against Additional paid-in capital Deferred Offering Costs Amortized Against Additional Paid-In Capital Deferred offering costs amortized against additional paid-in capital. Medicare Medicare [Member] Medicare. Operating lease expense Operating Lease, Expense Business Acquisition Business Acquisition [Axis] Class of Warrant or Right Class of Warrant or Right [Axis] Minimum cash balance at maturity date. Minimum cash balance at maturity date Minimum cash balance at maturity date Accounting Standards Update and Change in Accounting Principle [Abstract] Series A-1 Preferred Stock Series A1 Preferred Stock [Member] Series A-1 preferred stock. Income Tax Disclosure [Abstract] Oncimmune Limited Oncimmune Limited [Member] Oncimmune Limited. Finite-Lived Intangible Assets by Major Class Finite-Lived Intangible Assets by Major Class [Axis]